Genetic and Metabolic Determinants of Plasminogen Activator Inhibitor 1 (PAI-1) in Tunisian Type 2 Diabetes Patients

ISSN Print: 2165-7424
ISSN Online: 2165-7432
www.scirp.net/journal/ojemd
E-mail: [email protected]

Citations

"Genetic and Metabolic Determinants of Plasminogen Activator Inhibitor 1 (PAI-1) in Tunisian Type 2 Diabetes Patients"
written by Mohamed Moustapha, Molka Chadhli-Chaieb, Touhami Mahjoub, Larbi Chaieb,
published by Open Journal of Endocrine and Metabolic Diseases, Vol.7 No.6, 2017

has been cited by the following article(s):

[1]	Combating atherosclerosis with targeted Diosmin nanoparticles-treated experimental diabetes
	2020

[1]	A Narrative Review on Abnormalities in the Hemostatic System in Diabetes Mellitus: Pathophysiology, Clinical Implications, and Therapeutics Life, 2026 DOI:10.3390/life16040648

[2]	Combating atherosclerosis with targeted Diosmin nanoparticles-treated experimental diabetes Investigational New Drugs, 2020 DOI:10.1007/s10637-020-00905-6